Change 5-day change 1-year change 3-year change Capi.($)
+2.42%-.--% - - 0
-0.46%+10.31%+63.52%+143.15% 1,257B
-0.97%+1.60%+43.25%+80.09% 651B
-2.05%+0.73%+32.47%+101.62% 510B
-1.54%+0.18%+53.42%+66.79% 388B
-0.78%+5.51%+72.55%+44.25% 366B
-1.69%+3.17%+32.49%+55.35% 303B
-0.72%+7.83%+11.15%+33.76% 288B
-0.12%+4.68%+55.97%+74.59% 252B
-0.21%+7.34%+42.19%+109.69% 211B
Average -0.54%+4.59%+45.22%+78.81% 469.63B
Weighted average by Cap. -0.73%+5.30%+49.19%+93.33%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-